Preparing for out-of-season influenza epidemics when international travel resumes


Posted: 2021-11-13 20:00:00
Editorial Med J Aust . 2021 Nov 13. doi: 10.5694/mja2.51340. Online ahead of print. Affiliations Expand Affiliation 1 WHO Collaborating Centre for Reference and Research on Influenza (Royal Melbourne Hospital) at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC. Item in Clipboard Editorial Sheena G Sullivan. Med J Aust. 2021. Show details Display options Display options Format Med J Aust . 2021 Nov 13. doi: 10.5694/mja2.51340. Online ahead of print. Affiliation 1 WHO Collaborating Centre for Reference and Research on Influenza (Royal Melbourne Hospital) at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC. Item in Clipboard CiteDisplay options Display options Format No abstract available Keywords: COVID-19; Epidemics; Influenza; Vaccination. References Marsh CK, Sheppeard V, Tobin S, et al. Drivers of the summer influenza epidemic in New South Wales, 2018-19. Med J Aust 2022; https://doi.org/10.5694/mja2.51266 [online ahead of print]. https://www.mja.com.au/journal/2021/216/1/drivers-summer-influenza-epide... Geoghegan JL, Saavedra AF, Duchêne S, et al. Continental synchronicity of human influenza virus epidemics despite climactic variation. PLoS Pathog 2018; 14: e1006780. Sullivan SG, Carlson S, Cheng AC, et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill 2020; 25: 2001847. Prime Minister of Australia. Next steps to reopen to the world, 2021 [media release]. 1 Oct 2021. https://www.pm.gov.au/media/next-steps-reopen-world (viewed Oct 2021). Tamerius JD, Shaman J, Alonso WJ, et al. Environmental predictors of seasonal influenza epidemics across temperate and tropical climates. PLoS Pathog 2013; 9: e1003194. Show all 11 references Publication types Grant support

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
1月 29, 2021 バイオアソシエイツ

臍帯間葉系幹細胞による重度COVID-19治療で画期的な成果が報告された

マイアミ大学ミラー医学部の研究者らは、臍帯由来の間葉系幹細胞の注入によって最も重症の COVID-19 患者の死亡リスクを安全に減らし、回復までの時間を短縮することを示す、ユニークで画期的なランダム化比較試験を主導した。 STEM CELLS Translational Medicineで2021年1月5日に掲載されたこのオープンアクセス論文は「COVID-19急性呼吸窮迫症候群の臍帯間葉系幹細胞:二重盲検、フェーズ1 / 2a、ランダム化比較試験(Umbilical Cord Mesenchymal Stem…

ゲスト 608人 と メンバー 6人 がオンラインです